Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Activate Your Account with an access code or Create a New Account
The Stanford Heart Transplant Program has the accumulated wisdom of more than fifty years of research and patient care experience.
Our doctors and scientists work, collaboratively, to develop many
innovations and continue to advance new techniques in transplant
surgery.
The Stanford Hospital Heart Transplant Program has established a comprehensive Quality and Clinical Effectiveness Program to improve patient outcomes and satisfaction after undergoing heart transplantation. We monitor hospital length of stay, re-hospitalization rates, acute rejection rates, patient satisfaction scores, and national quality data from the University HealthSystem Consortium to help us identify areas for improvement and to monitor the effectiveness of our quality improvement initiatives.
Many patients referred to Stanford Health Care for heart transplantation are very sick and may have other medical conditions or heart failure complications that decrease their chances for survival after a heart transplant. The mortality Observed to Expected (O/E) ratio compares patients' actual mortality rates to their expected mortality rates--which take into account the severity of a patient's illness. An O/E ratio of 1.0 indicates that the observed mortality rate equaled the expected mortality rate based on patients' level of illness, while a lower O/E mortality ratio means that more patients survived than were expected due to the severity of their illness. The O/E mortality ratio among patients undergoing heart transplantation at Stanford has been declining steadily since 2009.
The Heart Transplant Quality Council is a multidisciplinary committee consisting of cardiologists, cardiothoracic surgeons, advanced practice nurses, nurse coordinators, patient care unit managers, social workers and other members of the heart transplant team who meet monthly to monitor and address quality data and patient adverse events, and to oversee the program's quality initiatives. Some of the quality initiatives being implemented by the Quality Council to improve survival and patient satisfaction after a heart transplant include:
This unusual procedure, known as a "domino" transplant, occurs when one recipient receives a heart-lung transplant from a deceased donor, while the existing healthy heart of the heart-lung recipient is given to a second patient. The rare procedure has only been performed eight times at Stanford, last in 1994.
With a new heart, a college athlete worked to become a model of fitness and a multiple medal winner in the annual transplant games.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Your doctor may request an evaluation by a heart failure specialist, who will review your medical records and determine if additional tests are necessary.
Patients being considered for a heart transplant will be referred to the Cardiomyopathy Center.
Self-referrals are accepted.
Bring results from prior lab tests, if requested.
Reach a transplant nurse coordinator at 650-498-9909.
Learn more about what
to expect during the different stages of a heart
transplant.
International Patients
Phone: +1 1-650-723-8561
Email: IMS@stanfordhealthcare.org
New to the clinic? Click below to book your first appointment with us.
To request an appointment by phone, call 650-723-5468.
